Steroid withdrawal methods with beclomethasone dipropionate inhaler (BDI) from maintenance systemic corticosteroids in steroid-dependent asthmatics were studied based on the results of a BDI questionnaire survey, copies of which were sent to 19 institutions studying asthma in various parts of Japan.
1) Steroid withdrawal was easier in moderate patients than in severe patients. When the daily maintenace dosage was 10mg or less of prednisolone or 1.0mg or less of betamethasone, many cases could reduce to less than a half of the initial daily dosage, then some of them could withdraw completely after administration of BDI for more than one year.
2) Steroid withdrawal is difficult in severe patients. Many patients whose maintenance daily dosage was 5mg or less of prednisolone could reduce to less than a half of the initial daily dosage within five months and moreover could withdraw within one year. Extension of triamcinolone acetonide (TA) injection periods could be observed in many patients treated with TA.
On the other hand, when their maintenace daily dosage was been between 5, 10mg of prednisolone, the reduction rate after one and a half years BDI treatment was about 50% on average. In the patients whose maintenance daily dosage was more than 10mg of prednisolone, the average reduction rate was between 60% and 70% after long-term BDI administration, but further reduction after reduction to around 5mg/day was not so easy. The reduction rate in patients treated with betamethasone was approximately 50% the initial daily dosage after one year of BDI administration.
3) Effects of transfer from systemic corticosteroids to BDI differed according to the kind of systemic corticosteroids. The ratio of steroid reduction effect between prednisolone and betamethasone with BDI was 1:18-1:35, approximately the same as the ratio of adrenal function supressing effect.
4) Reduction of BDI dosage could be seen at five to six months of BDI administration in cases in which BDI was effective moreover in excellent cases BDI daily dosage was 2 to 4 puffs at 10 months to 1 year.
5) Discontinuance of BDI administration in BDI non-response patients should be judged carefully.
View full abstract